ACRS

ACRS Operating Cash Flow (Statement)

-$62.06MTTM · USD

Period ending:

ACRS FY Cash from OperationsUSD
ACRS FY Cash from Operations2013-12-31: -$4.92M2014-12-31: -$7.64M2015-12-31: -$20.37M2016-12-31: -$34.60M2017-12-31: -$54.66M2018-12-31: -$100.81M2019-12-31: -$96.45M2020-12-31: -$38.63M2021-12-31: -$52.13M2022-12-31: -$67.57M2023-12-31: -$78.33M2024-12-31: -$20.08M2025-12-31: -$47.11M$0.00-$100.81M
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ACRS operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Aclaris Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-47,113,000
-20,075,000
-78,325,000
-67,567,000
-52,134,000
-38,633,000
-96,445,000
-100,811,000
-54,663,000
-34,603,000
-20,369,000
-7,636,000
-4,920,000

Compare operating cash flow (statement)

All ACRS financial metrics · ACRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.